[{"Assets_0_Q1_USD":418019000.0,"EarningsPerShareBasic_1_Q1_USD":0.19,"EarningsPerShareDiluted_1_Q1_USD":0.19,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":22930000.0,"NetIncomeLoss_1_Q1_USD":2250000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":46483000.0,"StockholdersEquity_0_Q1_USD":179644000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":11706000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":11589000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180508"}]